Professor Andrew W Bradbury
BSc MB ChB (Hons) MBA MD FEBVS FRCSEd FRCSEng.
Sampson Gamgee Professor of Vascular Surgery, University of Birmingham, UK
Prof. Bradbury took up post as the Sampson Gamgee Professor of Vascular Surgery, University of Birmingham, and Honorary Consultant Vascular Surgeon at Heart of England (now University Hospitals Birmingham) NHS Foundation Trust, in January 2000 having previously worked as an academic Consultant Vascular Surgeon at the University of Edinburgh since 1995. Andrew Chairs the UK NIHR HTA Hospital-based Care Committee and is also a member of the UK NIHR HTA Programme Oversight Committee. Andrew also is Chairing the UK NICE Abdominal Aortic Aneurysm (AAA) national Guideline Committee (GC). Recent publication highlights include the UK NIHR HTA funded EVRA trial results in the NEJM and publication of the Global Vascular Guidelines (GVG) on Chronic Limb Threatening Ischaemia (CLTI) in the JVS and EJVES. The long-term results of the NIHR HTA funded EVRA trial, and the main results of the NIHR HTA funded GAPS trial, have been submitted for publication. Andrew is Chief Investigator for the UK NIHR HTA funded BASIL 2 and BASIL 3 trials. Both trials are very close to 85% recruitment. Andrew is a co-applicant on the UK NIHR HTA funded CHAPS trial which will start randomising patients later this year. Andrew now Chairs the Scientific Committee, and sits on the Executive Committee of, the International Union of Phlebology (IUP); and has been appointed Associate Editor (IUP affairs) of the journal Phlebology. Andrew continues to sit on the Council of the World Federation of Vascular Societies.